ITRI.NASDAQItron, INC

Form 4: Itron Director Sanjay Mirchandani Reports Acquisition of Common Stock

Sentiment:

SEC Form 4 Filing


Director Sanjay Mirchandani reported acquiring 475 shares of Itron, Inc. common stock on October 1, 2024, as part of his board compensation.

Summary

  • Sanjay Mirchandani, a director of Itron, Inc., filed a Form 4 on October 2, 2024, reporting a transaction.
  • On October 1, 2024, Mirchandani acquired 475 shares of Itron common stock.
  • The acquisition was a grant of common stock received as part of the annual compensation for board service.
  • The price per share was $0.
  • Following the transaction, Mirchandani beneficially owns 3,351 shares of Itron common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to director compensation. The acquisition of shares by a director is generally viewed as a slightly positive sign, but it's not a major event.

Positives

  • The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a director's acquisition of company stock as part of their compensation, which is a common practice.

Stakeholder Impact

  • The transaction has a minimal impact on stakeholders as it is a routine part of director compensation.

Key Dates

DateDescription
10/01/2024Date of transaction: Sanjay Mirchandani acquired 475 shares of Itron common stock.
10/02/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.